{"database": "lobbying", "table": "lobbying_activities", "rows": [[3187149, "2a255ad4-4f9d-4ca0-a429-b0a64c7c04f9", "Q2", "THE VOGEL GROUP", 401104734, "HEALTHCARE SUPPLY CHAIN ASSOCIATION", 2024, "second_quarter", "MMM", "Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30400, null, 0, 0, "2024-07-09T12:05:45-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3187149"], "units": {}, "query_ms": 0.6508799269795418, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}